News

The Sheffield Academic Directorate of Respiratory Medicine contributed to a number of clinical research articles which were published in 2016. A listing with links can be found on our Publications page: see www.lungsheffield.org/research...

The Pulmonary Hypertension Association UK held a meeting for patients, their families, and staff from the Royal Hallamshire Hospital Pulmonary Vascular Disease Unit on 12th November at the Hilton Hotel in Sheffield. Staff from the PVDU gave presen...

The STH Interstitial Lung Disease service led by Dr Stephen Bianchi has initiated a clinical trial sponsored by Boehringer-Ingelheim. The trial will investigate if combining two drugs, Nintedanib and Sildenafil, is effective in treatment of idiopa...

Prof Ian Sabroe and the RHH Clinical Research Facility have initiated a clinical trial investigating Fevipiprant, a new treatment which can be taken orally as a tablet, developed by Novartis for people with severe asthma. Previous research has sho...

the Sheffield Clinical Research Office has published its third Newsletter about Patient and Public Involvement in clinical research. Click here for details http://www.lungsheffield.org/files/document/39/PPI%20Newsletter%203rd%20ed..pdf

A trial sponsored by Novartis will build on previous research involving STH Respiratory Medicine (Dr Rod Lawson) and the University of Sheffield (Prof Jim Wild). The trial will study the effects of a combination inhaled drug therapy (LABA/LAMA) in...

A team from Sheffield Teaching Hospitals have trialled a new treatment procedure for people with pulmonary hypertension, a condition affecting the lungs and heart. Dr Alex Rothman and a research team from the directorates of Cardiology, Respirator...

Dr Hui Hoo, who is funded by an NIHR Research Fellowship, has won a poster prize at the International European Cystic Fibrosis Conference. This important award reflects the recognition that this work represents a way to shift CF care from expensi...

International Clinical Trials Day commemorates the day in 1747 that James Lind started his trial on the deadly disease scurvy. The trial consisted of 12 sailors with scurvy, given a variety of dietary supplements from cider to oranges and lemons. ...

New study: A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension Inflammation and autoimmunity have an important role in Pulmonary Hypertension, a serious condition characterised by raised blood pressur...